MARX Biotech Co (7731.TWO) Stock Price

MARX Biotech Co Price

CLOSED
4.31
​
Market closed

Over the last 4 years MARX Biotech Co grew revenue by 58.9% annually, reaching 622.16 M TWD. Earnings per share have grown at 32.9% per year over the last 4 years. For MARX Biotech Co, the net margin of 6.9% is down versus 14.1% a few years ago.

MARX Biotech Co stock price

Access this data via the Eulerpool API

MARX Biotech Co business model & stock analysis

MARX Biotech Co Ltd is a TW-based company operating in industry. The company is headquartered in Taipei, New Taipei. The company went IPO on 2024-02-05. MARX Biotech Co Ltd is a Taiwan-based retail company that develops with data-driven innovation strategies. The firm's main product types span health foods, skin care products, hair products, health products and cleaning products, and are sold on domestic brand official sales platforms, e-commerce platforms, chain and small and medium-sized cosmeceutical pharmacies, and overseas cross-border e-commerce channels. The firm mainly operates four major brands, including the high-end men's health brand TAIZAKU, the skin care and health care brand Inyouso, the sports and children's health care brand Phargoods, and the beauty care brand SnowIOU.

Frequently asked questions about MARX Biotech Co

Converted at the current exchange rate, the MARX Biotech Co share trades at 0.12 EUR (4.31 TWD).

The revenue cannot currently be calculated for MARX Biotech Co.

The profit cannot currently be calculated for MARX Biotech Co.

The P/E ratio cannot be calculated for MARX Biotech Co at the moment.

The P/S cannot be calculated for MARX Biotech Co currently.

The Eulerpool Quality Score for MARX Biotech Co is 2/10.

The ISIN of MARX Biotech Co is TW0007731002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of MARX Biotech Co is 7731.TWO. The ticker symbol is used to trade MARX Biotech Co shares on the stock exchange.

Fair ValueTerminal
4.18 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Feb 5, 2024
ISIN
TW0007731002
Cusip
Y8485B105
Market capitalization
2.25 B TWDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
6.26
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
8.20 %
Last updated Oct 11, 2026, 4:54 PM

MARX Biotech Co Peer Group